TPMT and inflammatory bowel disease: The Food and Drug Administration (FDA) still indicates genotyping or phenotyping before drug administration to identify TPMT status[88], while the American College of Gastroenterology indicates phenotyping as the first choice for patients using thiopurines for IBD because phenotyping reports a quantitative level of TPMT enzyme activity[89].